No Matches Found
No Matches Found
No Matches Found
Aptorum Group Ltd.
Is Aptorum Group Ltd. technically bullish or bearish?
As of November 1, 2023, there is not enough technical data to assess the current stance of Aptorum Group Ltd.
Who are in the management team of Aptorum Group Ltd.?
As of March 2022, the management team of Aptorum Group Ltd. includes President and Executive Director Mr. Darren Lui, CEO and Founder Mr. Ian Huen, Chief Medical Officer Dr. Clark Cheng, and several Non-Executive Independent Directors: Mr. Douglas Arner, Mr. Charles Bathurst, Dr. Mirko Scherer, and Dr. Justin Wu.
What does Aptorum Group Ltd. do?
Aptorum Group Ltd. is a pharmaceutical company focused on developing treatments for infectious diseases and oncology, with a market capitalization of $7.79 million. Key financial metrics include a debt equity ratio of 0.12 and a return on equity of -14.26%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

